# Alnylam Q3 Revenue Rises 17%

> Alnylam's Q3 revenue jumps 17% to $1.46 billion as net product revenue surges 52%.
- Title: Alnylam Q3 Revenue Rises 17% · TokenPost | Shortify
- Summary: Alnylam's Q3 revenue jumps 17% to $1.46 billion as net product revenue surges 52%. Alnylam Pharmaceuticals reported $1.458 billion Q3 revenue, a 17%…
- Keywords: alnylam, revenue, net product revenue, 1.458 billion, 1.292 billion, 17%, 52%, 2026 forecast, 4.7 billion, 4.5 billion, crypto, Rises
- Source: TokenPost — https://tokenpost.com/news/business/43613
- Published: 2026-10-29T14:51:45+00:00
- Read time: 1 min
- Topics: alnylam, q3, revenue, net product revenue, 1.458 billion, 1.292 billion, 17%, 52%, 2026 forecast, 4.7 billion, 4.5 billion, crypto
## Alnylam Q3 Revenue
Alnylam Pharmaceuticals recorded $1.458 billion in revenue for the quarter ended Sept. 30, a 17% increase from a year earlier.
## Net Product Revenue Jump
Net product revenue climbed 52% to $1.292 billion, while diluted non-GAAP earnings per share reached $16.26.
## 2026 Revenue Forecast
Alnylam reaffirmed its 2026 forecast for total net product revenue of $4.7 billion to $5.1 billion.
## Key takeaway

Alnylam Pharmaceuticals reported $1.458 billion Q3 revenue, a 17% year-over-year increase, with net product revenue up 52% to $1.292 billion.